Effectiveness of the Dual Serotonin Norepinephrine Reuptake Inhibitor Venlafaxine in Depressed Patients
This study is recruiting. It focuses on depression and currently lists participation information in Canada.
In Canada
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting. It focuses on depression and currently lists participation information in Canada.
In CanadaThis study is recruiting. It focuses on depression and currently lists participation information in Spain.
In SpainThis study is recruiting. It focuses on depression and currently lists participation information in Ireland.
In IrelandThis study is recruiting. It focuses on anxiety and currently lists participation information in Taiwan.
In TainanThis study is recruiting. It focuses on addiction and currently lists participation information in the United States.
In San Luis ObispoThis study is recruiting. It focuses on depression and currently lists participation information in Norway.
In NorwayThis study is recruiting. It focuses on suicide prevention and currently lists participation information in Canada.
In CanadaThis study is recruiting. It focuses on PTSD and currently lists participation information in the United States.
Multiple locations, including Little RockThis study is recruiting. It focuses on anxiety and currently lists participation information in Norway.
Multiple locations, including BergenThis study is recruiting. It focuses on anxiety and currently lists participation information in Sweden.
In SwedenThis study is recruiting. It focuses on depression and currently lists participation information in France.
In PoitiersThis study is recruiting in France and in Spain. It focuses on depression.
In FranceHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.